Medicare decides on PET (positron emission tomography) in breast cancer screening
This article was originally published in Clinica
Executive Summary
A panel of experts that advises the federal government on Medicare coverage issues has recommended only one use for positron emission tomography (PET) in evaluating breast cancer.